Ilex Medical Ltd (TLV:ILX)

Ilex Medical Balance Sheet

Financials in millions ILS. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	163.3	177.25	148.38	200.96	259.23	159.83
Short-Term Investments	26.77	25.87	41.25	2.74	-	-
Trading Asset Securities	49.8	33.76	27.48	22	25.52	15.93
Cash & Short-Term Investments	239.86	236.88	217.11	225.7	284.75	175.75
Cash Growth	32.52%	9.11%	-3.81%	-20.74%	62.02%	101.31%
Accounts Receivable	227.88	249.37	286.25	248.26	219.99	239.46
Other Receivables	6.02	17.56	15.57	3.04	3.73	0.38
Receivables	233.89	266.93	301.82	251.3	223.72	239.84
Inventory	186.2	157.89	159.68	145.8	116.32	136.68
Other Current Assets	24.25	56.77	7.39	12.02	6.93	6.72
Total Current Assets	684.2	718.47	686.01	634.83	631.72	558.99
Property, Plant & Equipment	153.15	155.46	160.91	145.28	151.41	154.78
Long-Term Investments	67	53.71	57.95	72.66	32.1	0.45
Goodwill	7.01	7.01	7.01	7.01	-	-
Other Intangible Assets	13.63	17.08	21.27	25.06	25.87	31.69
Long-Term Accounts Receivable	38.84	34.91	28.51	5.73	3.75	6.42
Long-Term Deferred Tax Assets	6.09	7.42	8.51	6.35	6.35	4.46
Long-Term Deferred Charges	-	-	-	0.04	0.08	0.08
Other Long-Term Assets	0.01	0.01	45.95	2.23	23.8	22.38
Total Assets	969.92	994.07	1,016	899.18	875.07	779.25
Accounts Payable	129.37	120.44	172.11	142.32	124.39	162.79
Accrued Expenses	-	-	-	-	-	40.2
Short-Term Debt	-	-	-	-	-	0.22
Current Portion of Long-Term Debt	-	0.31	0.41	0.56	1.13	15.27
Current Portion of Leases	12.33	12.22	11.47	12.28	11.96	8.56
Current Income Taxes Payable	5.49	4.5	1.4	2.22	40.39	7.22
Current Unearned Revenue	42.56	-	-	-	-	33.4
Other Current Liabilities	49.14	130.4	93.15	68.45	62.23	11.58
Total Current Liabilities	238.89	267.87	278.54	225.83	240.11	279.22
Long-Term Debt	-	-	0.31	0.73	1.29	2.42
Long-Term Leases	36.64	38.81	36.07	37.99	44.36	40.28
Long-Term Unearned Revenue	8.01	25.28	60.33	4.11	-	6.08
Pension & Post-Retirement Benefits	0.96	0.96	1.63	-	-	-
Long-Term Deferred Tax Liabilities	2.22	2.55	2.94	3.15	6.72	7.58
Other Long-Term Liabilities	9.47	12.12	12.77	14.28	7.02	0.12
Total Liabilities	296.18	347.58	392.61	286.08	299.49	335.71
Common Stock	12.48	12.48	12.48	12.48	12.48	12.48
Additional Paid-In Capital	150.5	150.5	150.5	150.5	150.5	150.5
Retained Earnings	591.96	568.58	544.92	515.41	472.39	334.63
Treasury Stock	-9.2	-9.2	-9.2	-3.49	-	-
Comprehensive Income & Other	-71.99	-75.86	-75.19	-61.79	-59.79	-54.07
Total Common Equity	673.74	646.49	623.51	613.1	575.57	443.54
Shareholders' Equity	673.74	646.49	623.51	613.1	575.57	443.54
Total Liabilities & Equity	969.92	994.07	1,016	899.18	875.07	779.25
Total Debt	48.96	51.35	48.27	51.55	58.74	66.74
Net Cash (Debt)	190.9	185.53	168.84	174.15	226.02	109.01
Net Cash Growth	50.55%	9.88%	-3.04%	-22.95%	107.33%	-
Net Cash Per Share	17.08	16.58	15.09	15.44	20.04	10.22
Filing Date Shares Outstanding	11.21	11.19	11.28	11.28	11.28	11.28
Total Common Shares Outstanding	11.21	11.19	11.19	11.25	11.28	11.28
Working Capital	445.31	450.6	407.47	409	391.61	279.77
Book Value Per Share	60.09	57.78	55.73	54.52	51.02	39.32
Tangible Book Value	653.11	622.4	595.24	581.04	549.7	411.85
Tangible Book Value Per Share	58.25	55.63	53.20	51.67	48.73	36.51
Land	-	0.06	0.06	0.06	0.06	0.06
Machinery	-	254.19	244.49	212.94	193.36	188.2
Leasehold Improvements	-	17.78	25.19	24.04	25.51	25.36

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.